One year since Zimmer Biomet signed the agreement to acquire the medical device company, Embody has continued to operate, selling its patented Tapestry implants for tendon and ligament repair and arthroscopy.
However, since the acquisition, Embody has not debuted any new devices or implants on its website. The company’s CEO, Jeffrey Conroy, has remained unchanged since Zimmer Biomet’s acquisition.
Zimmer Biomet now holds Embody’s patents for the Tapestry implant, according to a 2023 update to its website.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
